XML 37 R24.htm IDEA: XBRL DOCUMENT

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	17. Subsequent Events On February 23, 2018, we initiated a voluntary recall of a specific laser accessory called the TruFocus LIO Premiere™ (“LIO”). The LIO is a headmounted indirect ophthalmoscopes that connects to our laser console and is used to view and perform retina laser treatment on a patient’s eye. There are 104 TruFocus LIO Premiere units at customer sites worldwide. We have received reports of three adverse events occurring during procedures in which the TruFocus LIO Premiere was used. Iridex has notified the FDA of this action. Recalled products were manufactured from May 26, 2017 to November 6, 2017 and distributed from June 5, 2017 to January 29, 2018. As a consequence of the recall program, the Company has estimated a decrease of $0.8 million in the fourth quarter of fiscal year 2017 revenues due to an increase in sales return allowance. Cost of sales increased by $1.3 million related to inventory write-down, replacement and other associated warranty costs. All of these financial impact has been reflected within the December 30, 2017 financial statements.